[Current status of gynecologic hormone therapy. Prolactin-induced disorders].
D000236:Adenoma / Q000188:drug therapy; D001971:Bromocriptine / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D007247:Infertility, Female / Q000188:drug therapy*; D007986:Luteinizing Hormone / Q000097:blood; D010911:Pituitary Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D011388:Prolactin / Q000097:blood
D001971:Bromocriptine; D011388:Prolactin; D007986:Luteinizing Hormone
Derzeitiger Stand der gynäkologischen Hormontherapie. Prolaktinbedingte Störungen.